Suppr超能文献

“共配体”对99mTc标记的肼基烟酸衍生化趋化肽生物分布的影响。

Effect of "co-ligand" on the biodistribution of 99mTc-labeled hydrazino nicotinic acid derivatized chemotactic peptides.

作者信息

Babich J W, Fischman A J

机构信息

Department of Radiology, Massachusetts General Hospital, Boston 02114, USA.

出版信息

Nucl Med Biol. 1995 Jan;22(1):25-30. doi: 10.1016/0969-8051(94)00081-t.

Abstract

Hydrazinonicotinamide (HYNIC) derivatized chemotactic peptides radiolabeled with 99mTc- (via 99mTc-glucoheptonate) have been demonstrated to be useful for infection imaging [J. Nucl. Med. 34, 1964-1974 (1993)]. Since HYNIC can occupy only two sites of the technetium co-ordination sphere, the labeled product most probably contains additional ligands. Thus we hypothesized that glucoheptonate serves this role by acting as a "'co-ligand'". Due to the low molecular weight of the chemotactic peptides, the "co-ligand" used for technetium labeling could have profound effects on biodistribution. To evaluate this possibility, we measured the biodistribution of 99mTc-labeled For-MLFK-HYNIC radiolabeled using four different "co-ligand"s: glucarate, glucoheptonate, mannitol and glucamine, providing a small series of hydroxyl-backbone ligands which differ in the number and type of ionizable functional groups present. Each preparation was injected into groups of 6 rats (approximately 10 microCi/rat) and biodistribution was determined at 5, 30, 60 and 120 min. Although small differences in biodistribution were detected in most tissues, the most prominent differences (P < 0.01) were observed in lung (glucoheptonate, glucarate > mannitol >> glucamine), liver (glucarate, glucoheptonate, mannitol >> glucamine), kidney (mannitol > glucarate, glucoheptonate, glucamine), spleen (glucarate >> glucoheptonate, mannitol >> glucamine) and GI-tract (glucarate, glucamine >> gluco-heptonate >> mannitol). These results provide support for the "co-ligand" hypothesis and indicate that the nature of the "co-ligand" can have profound effects on biodistribution. Although radiolabeling using glucamine as the "co-ligand" results in the lowest concentrations of radioactivity in most organs, the extremely low concentration of mannitol-labeled peptide in the GI-tract suggests that this may be the "co-ligand" of choice for most applications.

摘要

已证明用99mTc(通过99mTc-葡庚糖酸盐)进行放射性标记的肼基烟酰胺(HYNIC)衍生化趋化肽可用于感染成像[《核医学杂志》34, 1964 - 1974 (1993)]。由于HYNIC仅能占据锝配位球的两个位点,标记产物很可能含有额外的配体。因此我们推测葡庚糖酸盐通过充当“共配体”发挥此作用。由于趋化肽分子量较低,用于锝标记的“共配体”可能对生物分布有深远影响。为评估这种可能性,我们测量了用四种不同“共配体”(葡糖醛酸盐、葡庚糖酸盐、甘露醇和葡糖胺)放射性标记的99mTc-For-MLFK-HYNIC的生物分布,提供了一小系列在可电离官能团的数量和类型上有所不同的含羟基主链配体。将每种制剂注射到6只大鼠组中(每只大鼠约10微居里),并在5、30、60和120分钟时测定生物分布。尽管在大多数组织中检测到生物分布存在微小差异,但在肺(葡庚糖酸盐、葡糖醛酸盐>甘露醇>>葡糖胺)、肝(葡糖醛酸盐、葡庚糖酸盐、甘露醇>>葡糖胺)、肾(甘露醇>葡糖醛酸盐、葡庚糖酸盐、葡糖胺)、脾(葡糖醛酸盐>>葡庚糖酸盐、甘露醇>>葡糖胺)和胃肠道(葡糖醛酸盐、葡糖胺>>葡庚糖酸盐>>甘露醇)中观察到最显著的差异(P<0.01)。这些结果为“共配体”假说提供了支持,并表明“共配体”的性质可能对生物分布有深远影响。尽管以葡糖胺作为“共配体”进行放射性标记在大多数器官中导致放射性浓度最低,但胃肠道中甘露醇标记肽的极低浓度表明,对于大多数应用而言,这可能是首选的“共配体”。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验